Dow Down 0.24% Nasdaq Up 0.10%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.47 Up 0.18(1.94%) 12:02PM EDT - Nasdaq Real Time Price
Prev Close:9.29
Open:9.26
Bid:9.47 x 300
Ask:9.48 x 700
1y Target Est:14.54
Beta:1.93078
Next Earnings Date: 9-Aug-16HALO Earnings announcement
Day's Range:9.22 - 9.55
52wk Range:6.96 - 25.00
Volume:440,556
Avg Vol (3m):1,458,910
Market Cap:1.22B
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Comparison

Symbol% ChgMkt Cap
HALOUp 1.94%1.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.03
Quarterly EPS Est (Jun-16) :-0.27
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback